Saved source observation · CN4171503

Procurement of Imported Plasma and Recombinant Products (IPRP) - Eloctate and Alprolix

This is the latest observation of this contract, and the explorer’s totals use its value.

$81,881,219.20

Full reported contract value · AUD including applicable GST · 2025-07-01 to 2028-06-30

Reporting agency
National Blood Authority
Reported supplier
Sanofi-Aventis Australia Pty Ltd
Reported ABN
31 008 558 807. Exemption as supplied: No.
Category
Drugs and Pharmaceutical Products
Procurement method
Open tender
Original publication
2025-07-18 15:52:00 (ACT local time as supplied)
Amendment publication
Original notice; no amendment publication supplied
Amendment reason
Not supplied
Agency reference
Not supplied
Approach to market / standing offer
CBP_CON_001 / Standing offer not supplied
Consultancy
No
Confidentiality as reported
Contract: Yes; outputs: No
Source observation
CN4171503 · Official weekly workbook ending 2025-07-19 · sheet “Contract Notice Export”, row 846.

The original register may now show later corrections. The card and this observation keep the saved source date.